Advancing Antibacterial Development for Severe Enteric Infections: Insights from GNA NOW on Target Product Profiles and Preclinical Models
The development of new antibiotics for severe enteric infections remains a critical global health priority, yet significant scientific and translational challenges continue to slow progress. As part of the GNA […]
